Memphasys Limited is a bio-separations company developing and commercializing separation techniques based on its membrane technology. It develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company's lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The Company's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.

Sales Analysis. During the year ended June of 2016, sales at Memphasys Ltd were A$63,960.00 (US$46.48 thousand). This is a sharp decrease of 66.5% versus 2015, when the company's sales were A$190,660.00 .